Andrew T. Yan, MD

Original Contribution

Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents – A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

09/15/2016

Jacob A. Udell , MD, MPH;

Shaun G. Goodman , MD, MSc;

Asim N. Cheema , MD, PhD;

Akshay Bagai , MD, MHS;

Anthony W.A. Wassef , MD;

Hadi Khafaji ;

Ishba Syed ;

Andrew T. Yan , MD;

Current guidelines recommend 12 months of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. We investigate whether the duration of DAPT can be safely shortened with use...

Current guidelines recommend 12...

09/15/2016

Journal of Invasive Cardiology

Original Contribution

Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome

07/30/2013

Loakim Spyridopoulos , MD;

Bernard D. Keavney , BM, BCh, DM;

Alan J. Bagnall , MBChB, PhD;

Sujith K. Seneviratne , MBBS, FRACP, MBChB;

Azfar G. Zaman , BSc, MD, FRCP, MBChB;

Andrew T. Yan , MD;

Mohaned Egred , MBChB, MD, BSc(Hons), FRCP, BSc, MRCP;

Athar Badar , MBChB;

Jennifer Scaife , MBChB;

Simon D. Robinson , MBChB, MD;

Ian F. Purcell , MBChB, MD, MRCP;

Javed M. Ahmed , MBBS, FRCP, MD;

Richard J. Edwards , MBChB, MD;

A retrospective analysis aims to determined whether high bleeding risk acute coronary syndrome patients taking DAPT were appropriately provided with GI prophylaxis and investigated the association between age and clinical presentation on the...

A retrospective analysis aims to...

07/30/2013

Journal of Invasive Cardiology